Published in Mol Ther on January 01, 2007
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature (2009) 11.27
Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc Natl Acad Sci U S A (2008) 4.98
Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet (2009) 3.86
Generation of an inducible and optimized piggyBac transposon system. Nucleic Acids Res (2007) 3.09
piggyBac can bypass DNA synthesis during cut and paste transposition. EMBO J (2008) 2.27
High-throughput insertional mutagenesis screens in mice to identify oncogenic networks. Nat Rev Cancer (2009) 2.06
Transposon-mediated genome manipulation in vertebrates. Nat Methods (2009) 1.96
Comparative analysis of transposable element vector systems in human cells. Mol Ther (2010) 1.66
piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies. Hum Gene Ther (2010) 1.64
Multiplexed transposon-mediated stable gene transfer in human cells. Proc Natl Acad Sci U S A (2010) 1.57
Genome-wide mapping of PiggyBac transposon integrations in primary human T cells. J Immunother (2009) 1.52
Protective role of insulin-like growth factor-1 receptor in endothelial cells against unilateral ureteral obstruction-induced renal fibrosis. Am J Pathol (2015) 1.45
Fifteen years of gene therapy based on chimeric antigen receptors: "are we nearly there yet?". Hum Gene Ther (2009) 1.44
Retracted Robust method for TALEN-edited correction of pF508del in patient-specific induced pluripotent stem cells. Stem Cell Res Ther (2016) 1.43
Translating Sleeping Beauty transposition into cellular therapies: victories and challenges. Bioessays (2010) 1.42
Gene transfer efficiency and genome-wide integration profiling of Sleeping Beauty, Tol2, and piggyBac transposons in human primary T cells. Mol Ther (2010) 1.38
piggyBac transposon-mediated long-term gene expression in mice. Mol Ther (2010) 1.33
Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytes. J Immunother (2009) 1.32
PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor. Mol Ther (2011) 1.32
Immunotherapy of human cancers using gene modified T lymphocytes. Curr Gene Ther (2009) 1.29
Technology transfer from worms and flies to vertebrates: transposition-based genome manipulations and their future perspectives. Genome Biol (2007) 1.29
Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy. Expert Opin Biol Ther (2011) 1.27
Efficient genetic modification and germ-line transmission of primordial germ cells using piggyBac and Tol2 transposons. Proc Natl Acad Sci U S A (2012) 1.26
Helper-independent piggyBac plasmids for gene delivery approaches: strategies for avoiding potential genotoxic effects. Proc Natl Acad Sci U S A (2010) 1.25
A method for stable transgenesis of radial glia lineage in rat neocortex by piggyBac mediated transposition. J Neurosci Methods (2012) 1.25
DNA transposons: nature and applications in genomics. Curr Genomics (2010) 1.25
PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer. Mol Ther (2009) 1.23
Transposon-mediated BAC transgenesis in human ES cells. Nucleic Acids Res (2012) 1.21
Hyperactive piggyBac gene transfer in human cells and in vivo. Hum Gene Ther (2011) 1.21
Genetically engineered mouse models in cancer research. Adv Cancer Res (2010) 1.18
Integration of reporter transgenes into Schistosoma mansoni chromosomes mediated by pseudotyped murine leukemia virus. FASEB J (2008) 1.18
Enzymatic engineering of the porcine genome with transposons and recombinases. BMC Biotechnol (2007) 1.14
Targeted plasmid integration into the human genome by an engineered zinc-finger recombinase. Nucleic Acids Res (2011) 1.13
Delivering the goods: viral and non-viral gene therapy systems and the inherent limits on cargo DNA and internal sequences. Genetica (2010) 1.13
Manipulating piggyBac transposon chromosomal integration site selection in human cells. Mol Ther (2011) 1.12
Chimeric piggyBac transposases for genomic targeting in human cells. Nucleic Acids Res (2012) 1.09
The expanding universe of transposon technologies for gene and cell engineering. Mob DNA (2010) 1.08
Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system. Hum Gene Ther (2009) 1.08
Transposon-mediated transgenesis, transgenic rescue, and tissue-specific gene expression in rodents and rabbits. FASEB J (2012) 1.07
Editing DNA Methylation in the Mammalian Genome. Cell (2016) 1.04
Combining mTor inhibitors with rapamycin-resistant T cells: a two-pronged approach to tumor elimination. Mol Ther (2011) 1.03
PiggyBac transposon-mediated, reversible gene transfer in human embryonic stem cells. Stem Cells Dev (2010) 1.00
Regulated gene insertion by steroid-induced PhiC31 integrase. Nucleic Acids Res (2008) 0.99
Simple piggyBac transposon-based mammalian cell expression system for inducible protein production. Proc Natl Acad Sci U S A (2013) 0.98
Genome-wide target profiling of piggyBac and Tol2 in HEK 293: pros and cons for gene discovery and gene therapy. BMC Biotechnol (2011) 0.98
"Calling cards" for DNA-binding proteins in mammalian cells. Genetics (2012) 0.97
Gene editing of human embryonic stem cells via an engineered baculoviral vector carrying zinc-finger nucleases. Mol Ther (2011) 0.97
Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery. Nucleic Acids Res (2011) 0.96
Transposons for cancer gene discovery: Sleeping Beauty and beyond. Genome Biol (2007) 0.96
Gene therapy for hemophilia. Front Biosci (Landmark Ed) (2015) 0.94
Pigs taking wing with transposons and recombinases. Genome Biol (2007) 0.94
Evaluation of long-term transgene expression in piggyBac-modified human T lymphocytes. J Immunother (2013) 0.94
Precise marker excision system using an animal-derived piggyBac transposon in plants. Plant J (2013) 0.94
A Hyperactive Transposase Promotes Persistent Gene Transfer of a piggyBac DNA Transposon. Mol Ther Nucleic Acids (2012) 0.93
Characterization of constitutive promoters for piggyBac transposon-mediated stable transgene expression in mesenchymal stem cells (MSCs). PLoS One (2014) 0.93
Generation of melanocytes from induced pluripotent stem cells. J Invest Dermatol (2011) 0.93
Hyperactive piggyBac transposons for sustained and robust liver-targeted gene therapy. Mol Ther (2014) 0.93
The piggyBac transposon-mediated expression of SV40 T antigen efficiently immortalizes mouse embryonic fibroblasts (MEFs). PLoS One (2014) 0.93
The construction of transgenic and gene knockout/knockin mouse models of human disease. Transgenic Res (2011) 0.91
Tumor-directed gene therapy in mice using a composite nonviral gene delivery system consisting of the piggyBac transposon and polyethylenimine. BMC Cancer (2009) 0.91
A simple and sensitive method for measuring tumor-specific T cell cytotoxicity. PLoS One (2010) 0.91
Passport, a native Tc1 transposon from flatfish, is functionally active in vertebrate cells. Nucleic Acids Res (2009) 0.91
Mechanism of sodium channel NaV1.9 potentiation by G-protein signaling. J Gen Physiol (2013) 0.90
piggyBac-ing models and new therapeutic strategies. Trends Biotechnol (2015) 0.89
Pogostick: a new versatile piggyBac vector for inducible gene over-expression and down-regulation in emerging model systems. PLoS One (2011) 0.89
DNA transposon-based gene vehicles - scenes from an evolutionary drive. J Biomed Sci (2013) 0.89
Crystallization of a Mos1 transposase-inverted-repeat DNA complex: biochemical and preliminary crystallographic analyses. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.89
Delivery of full-length factor VIII using a piggyBac transposon vector to correct a mouse model of hemophilia A. PLoS One (2014) 0.89
Recent molecular approaches to understanding astrocyte function in vivo. Front Cell Neurosci (2013) 0.88
Development of a hybrid baculoviral vector for sustained transgene expression. Mol Ther (2009) 0.88
Transposon tools hopping in vertebrates. Brief Funct Genomic Proteomic (2008) 0.87
Comparative analysis of the recently discovered hAT transposon TcBuster in human cells. PLoS One (2012) 0.87
Simple and efficient methods for enrichment and isolation of endonuclease modified cells. PLoS One (2014) 0.87
Sustained high level transgene expression in mammalian cells mediated by the optimized piggyBac transposon system. Genes Dis (2015) 0.87
Generation of transgenic pigs by cytoplasmic injection of piggyBac transposase-based pmGENIE-3 plasmids. Biol Reprod (2014) 0.86
Bacteriophage Mu integration in yeast and mammalian genomes. Nucleic Acids Res (2008) 0.86
CAR-T Cell Therapy for Lymphoma. Annu Rev Med (2015) 0.86
A transposon toolkit for gene transfer and mutagenesis in protozoan parasites. Genetica (2009) 0.85
Delineating cooperative responses of processive motors in living cells. Proc Natl Acad Sci U S A (2014) 0.85
The human application of gene therapy to re-program T-cell specificity using chimeric antigen receptors. Chin J Cancer (2014) 0.85
The impact of cHS4 insulators on DNA transposon vector mobilization and silencing in retinal pigment epithelium cells. PLoS One (2012) 0.85
Genetic manipulation of schistosomes--progress with integration competent vectors. Parasitology (2011) 0.84
Genetic screens using the piggyBac transposon. Methods (2010) 0.84
Modular assembly of transposon integratable multigene vectors using RecWay assembly. Nucleic Acids Res (2013) 0.84
Building a lineage from single cells: genetic techniques for cell lineage tracking. Nat Rev Genet (2017) 0.83
Transcriptional repression of the Dspp gene leads to dentinogenesis imperfecta phenotype in Col1a1-Trps1 transgenic mice. J Bone Miner Res (2012) 0.83
Genetically engineered T cells for the treatment of cancer. J Intern Med (2013) 0.83
Driving DNA transposition by lentiviral protein transduction. Mob Genet Elements (2014) 0.81
Genomic landscape of human, bat, and ex vivo DNA transposon integrations. Mol Biol Evol (2014) 0.81
A non-autonomous insect piggyBac transposable element is mobile in tobacco. Mol Genet Genomics (2014) 0.81
Post-integration silencing of piggyBac transposable elements in Aedes aegypti. PLoS One (2013) 0.81
Evaluating the potential for undesired genomic effects of the piggyBac transposon system in human cells. Nucleic Acids Res (2015) 0.81
Sleeping Beauty transposon mutagenesis in rat spermatogonial stem cells. Nat Protoc (2011) 0.81
Cancer gene discovery in mouse and man. Biochim Biophys Acta (2009) 0.81
Genome-wide Profiling Reveals Remarkable Parallels Between Insertion Site Selection Properties of the MLV Retrovirus and the piggyBac Transposon in Primary Human CD4(+) T Cells. Mol Ther (2016) 0.80
In and out of the rRNA genes: characterization of Pokey elements in the sequenced Daphnia genome. Mob DNA (2013) 0.80
Characterization of a group of MITEs with unusual features from two coral genomes. PLoS One (2010) 0.80
Pseudo attP sites in favor of transgene integration and expression in cultured porcine cells identified by Streptomyces phage phiC31 integrase. BMC Mol Biol (2013) 0.80
piggyBac transposon system modification of primary human T cells. J Vis Exp (2012) 0.80
Ultrasound directs a transposase system for durable hepatic gene delivery in mice. Ultrasound Med Biol (2013) 0.80
Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation (2007) 4.10
Molecular basis of an inherited epilepsy. Neuron (2002) 3.77
piggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells. Proc Natl Acad Sci U S A (2006) 3.35
Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest (2003) 3.00
Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation (2002) 2.98
KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. Circulation (2005) 2.78
Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation (2013) 2.66
Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation (2008) 2.56
Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study. J Infect Dis (2005) 2.43
Impact of genetics on the clinical management of channelopathies. J Am Coll Cardiol (2013) 2.30
Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation (2007) 2.28
Structure of KCNE1 and implications for how it modulates the KCNQ1 potassium channel. Biochemistry (2008) 2.22
Fibrocystin/polyductin modulates renal tubular formation by regulating polycystin-2 expression and function. J Am Soc Nephrol (2008) 2.04
Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women. Pharmacogenetics (2003) 2.03
Long QT syndrome-associated mutations in intrauterine fetal death. JAMA (2013) 2.00
NOS1AP is a genetic modifier of the long-QT syndrome. Circulation (2009) 2.00
Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome. J Am Coll Cardiol (2008) 1.91
Cardiac ion channels. Annu Rev Physiol (2002) 1.90
Myotonia congenita. Adv Genet (2008) 1.80
Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCN1A. J Neurosci (2003) 1.77
Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype. Circulation (2005) 1.77
Expression of multiple KCNE genes in human heart may enable variable modulation of I(Ks). J Mol Cell Cardiol (2005) 1.70
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest (2008) 1.69
Polymorphic ventricular tachycardia and KCNJ2 mutations. Heart Rhythm (2004) 1.68
Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation (2002) 1.65
Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy. Proc Natl Acad Sci U S A (2004) 1.65
KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet (2002) 1.60
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. Heart Rhythm (2008) 1.59
Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. J Am Coll Cardiol (2012) 1.58
Multiplexed transposon-mediated stable gene transfer in human cells. Proc Natl Acad Sci U S A (2010) 1.57
Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel. Circ Arrhythm Electrophysiol (2008) 1.53
The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum. Nat Genet (2002) 1.51
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. Circulation (2005) 1.48
A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes. Circ Cardiovasc Genet (2011) 1.48
Gene vector and transposable element behavior in mosquitoes. J Exp Biol (2003) 1.44
Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro. Circulation (2011) 1.38
Structural models for the KCNQ1 voltage-gated potassium channel. Biochemistry (2007) 1.38
Preparation, functional characterization, and NMR studies of human KCNE1, a voltage-gated potassium channel accessory subunit associated with deafness and long QT syndrome. Biochemistry (2007) 1.35
Functional zinc finger/sleeping beauty transposase chimeras exhibit attenuated overproduction inhibition. FEBS Lett (2005) 1.35
The genetic basis of variability in drug responses. Nat Rev Drug Discov (2002) 1.34
Haplotype diversity in four genes (CLCNKA, CLCNKB, BSND, NEDD4L) involved in renal salt reabsorption. Hum Hered (2007) 1.30
Novel calmodulin mutations associated with congenital arrhythmia susceptibility. Circ Cardiovasc Genet (2014) 1.27
Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants. Circ Res (2014) 1.27
Improved DNA sequencing quality and efficiency using an optimized fast cycle sequencing protocol. Biotechniques (2007) 1.26
Helper-independent piggyBac plasmids for gene delivery approaches: strategies for avoiding potential genotoxic effects. Proc Natl Acad Sci U S A (2010) 1.25
Mutant prenyltransferase-like mitochondrial protein (PLMP) and mitochondrial abnormalities in kd/kd mice. Kidney Int (2004) 1.24
Molecular, functional, and genomic characterization of human KCC2, the neuronal K-Cl cotransporter. Brain Res Mol Brain Res (2002) 1.24
Genome-wide association study of multiple congenital heart disease phenotypes identifies a susceptibility locus for atrial septal defect at chromosome 4p16. Nat Genet (2013) 1.23
Divergent biophysical defects caused by mutant sodium channels in dilated cardiomyopathy with arrhythmia. Circ Res (2007) 1.23
Strategy for encoding and comparison of gene expression signatures. Genome Biol (2007) 1.18
Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity. Clin Infect Dis (2006) 1.18
Genetic variation in the rhythmonome: ethnic variation and haplotype structure in candidate genes for arrhythmias. Pharmacogenomics (2009) 1.16
Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia. J Am Coll Cardiol (2012) 1.15
Single-channel properties of human NaV1.1 and mechanism of channel dysfunction in SCN1A-associated epilepsy. J Gen Physiol (2006) 1.14
Divergent sodium channel defects in familial hemiplegic migraine. Proc Natl Acad Sci U S A (2008) 1.13
Formation and loss of large, unstable tandem arrays of the piggyBac transposable element in the yellow fever mosquito, Aedes aegypti. Transgenic Res (2004) 1.13
Sodium channel dysfunction in intractable childhood epilepsy with generalized tonic-clonic seizures. J Physiol (2005) 1.12
Manipulating piggyBac transposon chromosomal integration site selection in human cells. Mol Ther (2011) 1.12
Developmentally regulated SCN5A splice variant potentiates dysfunction of a novel mutation associated with severe fetal arrhythmia. Heart Rhythm (2011) 1.11
Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type-dependent biophysical and pharmacological properties. Proc Natl Acad Sci U S A (2006) 1.11
KCNE4 can co-associate with the I(Ks) (KCNQ1-KCNE1) channel complex. FEBS J (2008) 1.10
Coupled analysis of gene expression and chromosomal location. Genomics (2005) 1.10
Genetic susceptibility to acquired long QT syndrome: pharmacologic challenge in first-degree relatives. Heart Rhythm (2005) 1.10
Impaired NaV1.2 function and reduced cell surface expression in benign familial neonatal-infantile seizures. Epilepsia (2008) 1.09
Chimeric piggyBac transposases for genomic targeting in human cells. Nucleic Acids Res (2012) 1.09
Functional characterization of recombinant human ClC-4 chloride channels in cultured mammalian cells. J Physiol (2002) 1.07
Nonfunctional SCN1A is common in severe myoclonic epilepsy of infancy. Epilepsia (2006) 1.07
In vivo identification of genes that modify ether-a-go-go-related gene activity in Caenorhabditis elegans may also affect human cardiac arrhythmia. Proc Natl Acad Sci U S A (2004) 1.07
Nav 1.1 dysfunction in genetic epilepsy with febrile seizures-plus or Dravet syndrome. Eur J Neurosci (2011) 1.07
Functional repair of a mutant chloride channel using a trans-splicing ribozyme. J Clin Invest (2002) 1.07
Impaired inactivation gate stabilization predicts increased persistent current for an epilepsy-associated SCN1A mutation. J Neurosci (2006) 1.06
Change of chloride ion channel conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle disuse. Brain (2002) 1.06
SCN1A splice variants exhibit divergent sensitivity to commonly used antiepileptic drugs. Epilepsia (2011) 1.06
Molecular physiology of renal ClC chloride channels/transporters. Curr Opin Nephrol Hypertens (2006) 1.04
Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes. PLoS One (2013) 1.04
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. Circ Cardiovasc Genet (2013) 1.03
Expression and transcriptional control of human KCNE genes. Genomics (2005) 1.03
Propranolol blocks cardiac and neuronal voltage-gated sodium channels. Front Pharmacol (2010) 1.03
Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block. J Physiol (2003) 1.02
Voltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibility. Proc Natl Acad Sci U S A (2011) 1.02
Differential gene expression between alate and dealate queens in the red imported fire ant, Solenopsis invicta Buren (Hymenoptera: Formicidae). Insect Biochem Mol Biol (2004) 1.01
Ranolazine selectively blocks persistent current evoked by epilepsy-associated Naν1.1 mutations. Br J Pharmacol (2010) 1.00
Factor V Leiden protects against blood loss and transfusion after cardiac surgery. Circulation (2003) 0.97
Cardiac potassium channel dysfunction in sudden infant death syndrome. J Mol Cell Cardiol (2007) 0.96
Nadolol block of Nav1.5 does not explain its efficacy in the long QT syndrome. J Cardiovasc Pharmacol (2012) 0.95
The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines. FASEB J (2003) 0.95
Transcriptional networks in epithelial-mesenchymal transition. PLoS One (2011) 0.95
Extracellular sodium interacts with the HERG channel at an outer pore site. J Gen Physiol (2002) 0.95
High-resolution mapping of the sodium channel modifier Scnm1 on mouse chromosome 3 and identification of a 1.3-kb recombination hot spot. Genomics (2003) 0.94
Web-based interrogation of gene expression signatures using EXALT. BMC Bioinformatics (2009) 0.94
SCN5A variation is associated with electrocardiographic traits in the Jackson Heart Study. Circ Cardiovasc Genet (2011) 0.93
High efficiency, site-specific excision of a marker gene by the phage P1 cre-loxP system in the yellow fever mosquito, Aedes aegypti. Nucleic Acids Res (2003) 0.93
The KATP channel is a molecular sensor of atrophy in skeletal muscle. J Physiol (2010) 0.93
Cloning and characterization of cDNAs encoding putative CTCFs in the mosquitoes, Aedes aegypti and Anopheles gambiae. BMC Mol Biol (2005) 0.93
Site-directed genome modification: nucleic acid and protein modules for targeted integration and gene correction. Trends Biotechnol (2005) 0.93
Trafficking-competent and trafficking-defective KCNJ2 mutations in Andersen syndrome. Hum Mutat (2006) 0.92
Mutant Mos1 mariner transposons are hyperactive in Aedes aegypti. Insect Biochem Mol Biol (2005) 0.92
Polymorphisms in beta-adrenergic receptor genes in the acquired long QT syndrome. J Cardiovasc Electrophysiol (2002) 0.92
Antiepileptic activity of preferential inhibitors of persistent sodium current. Epilepsia (2014) 0.91